Article

Effectiveness of Inactivated COVID-19 Vaccines Against COVID-19 Pneumonia and Severe Illness Caused by the B.1.617.2 (Delta) Variant: Evidence from an Outbreak in Guangdong, China

2021-08-05

Abstract excerpt

Background: Real-world evidence (RWE) of a vaccine supplements clinical trial data by providing information in populations differing from clinical trial populations, under different epidemiological situations, on alternative outcomes, or against different pathogen lineages. To date, RWE on inactivated COVID-19 vaccines against the highly transmissible SARS-CoV-2 B.1.617.2 (Delta) variant is limited, leaving an imp...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 321f216f-25f5-56fe-94c5-e2885a8b6591
DOI: 10.2139/ssrn.3895639

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Effectiveness of Inactivated COVID-19 Vaccines Against COVID-19 Pneumonia and Severe Illness Caused by the B.1.617.2 (Delta) Variant: Evidence from an Outbreak in Guangdong, ChinaDOI 10.2139/ssrn.3895639Read

Effectiveness of the WHO-authorized Covid-19 Vaccines: a Rapid Review of Global Reports till June 30, 2021Semantic proximity Read

Effectiveness of COVID-19 vaccines against delta variant (B.1.617.2): A meta-analysisSemantic proximity Read

Effectiveness of inactive COVID-19 vaccines against severe illness in B.1.617.2 (Delta) variant-infected patients in Jiangsu, ChinaSemantic proximity Read

Effectiveness of Covid-19 Vaccines against the SARS-COV-2-Delta (B.1.617.2) in China-A Real World StudySemantic proximity Read

Effectiveness of 2024–2025 COVID-19 Vaccination Against COVID-19 Hospitalization and Severe In-Hospital Outcomes — IVY Network, 26 Hospitals, September 1, 2024–April 30, 2025Semantic proximity Read

A systematic review of COVID-19 vaccine efficacy and effectiveness against SARS-CoV-2 infection and diseaseSemantic proximity Read

BNT162B2 mRNA Covid-19 Vaccine Effectiveness in the Prevention of SARS-CoV-2 Infection and Symptomatic Disease in the Medium - to Long-Term: A Retrospective Cohort StudySemantic proximity Read

Comparative effectiveness of COVID-19 vaccination against death and severe disease in an ongoing nationwide mass vaccination campaignSemantic proximity Read

Effectiveness of Covid-19 vaccines against symptomatic and asymptomatic SARS-CoV-2 infections in an urgent care settingSemantic proximity Read

Efficacy Estimates for Various COVID-19 Vaccines: What we Know from the Literature and ReportsSemantic proximity Read

Real-world effectiveness and non-inferiority evaluation and comparison of mRNA- and protein-based COVID-19 vaccines: a randomized study protocol (BEEHIVE)Semantic proximity Read

Vaccine effectiveness and duration of protection against symptomatic and severe Covid-19 during the first year of vaccination in FranceSemantic proximity Read